'Molecular glue' harnesses the power of the immune system to treat neuroblastoma
September 17, 2025
September 17, 2025
MEMPHIS, Tennessee, Sept. 17 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:
* * *
'Molecular glue' harnesses the power of the immune system to treat neuroblastoma
*
Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell state. Tumors may . . .
* * *
'Molecular glue' harnesses the power of the immune system to treat neuroblastoma
*
Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell state. Tumors may . . .
